Validation of Simplified Electrophysiological Examination in the Diagnosis of Critical Illness Myopathy or Neuropathy (CRIMINE-3)

December 10, 2019 updated by: Elisa Seghelini,MD, Università degli Studi di Brescia

Validation Study of Simplified Electrophysiological Examination in the Diagnosis of Critical Illness Myopathy or Neuropathy

Evaluate the accuracy, in the diagnosis of critical illness myopathy and / or neuropathy, of the simplified peroneal nerve test performed by a neurophysiopathology technician or by a neurophysiopathology doctor (as the gold standard) compared to the exam performed by an intensivist.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

130

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brescia, Italy, 25123
        • Spedali Civili

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Critically Ill Patients

Description

Inclusion Criteria:

- adult patients admitted to Intensive care unit

Exclusion Criteria:

  • patients in terminal conditions
  • patients with peroneal nerve exam not feasible ( for example with presence of prostheses, wounds, plaster casts, edema of the limbs)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
sensitivity and specificity of peroneal nerve test performed by a neurophysiopathologist compared to peroneal nerve test performed by an intensivist when peroneal nerve test is dichotomised in normal or abnormal
Time Frame: up to the comlpete execution of the two peroneal nerve exams,at most an hour
DTComPair-package in R
up to the comlpete execution of the two peroneal nerve exams,at most an hour
specificity of peroneal nerve test performed by a neurophysiopathologist compared to peroneal nerve test performed by an intensivist when peroneal nerve test is dichotomised in normal or abnormal
Time Frame: up to the comlpete execution of the two peroneal nerve exams, at most an hour
DTComPair-package in R
up to the comlpete execution of the two peroneal nerve exams, at most an hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
evaluation of concordance between peroneal nerve test performed by an intensivist compared to peroneal nerve test performed by a neurophysiopathologist considering the test as a continuous variable
Time Frame: up to the comlpete execution of the two peroneal nerve exams, at most an hour
It will be performed either using Bland-Altman plot and mix model effect
up to the comlpete execution of the two peroneal nerve exams, at most an hour
correlation between hospital mortality and abnormal peroneal nerve test
Time Frame: up to hospital discharge, an average of 6 months
Anova
up to hospital discharge, an average of 6 months
correlation between hospital discharge destination and abnormal peroneal nerve test
Time Frame: up to hospital discharge, an average of 6 months
Anova
up to hospital discharge, an average of 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Elisa Seghelini, II Servizio di Anestesia e Rianimazone, Spedali Civili

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 18, 2014

Primary Completion (ACTUAL)

November 26, 2014

Study Completion (ANTICIPATED)

May 1, 2020

Study Registration Dates

First Submitted

November 25, 2019

First Submitted That Met QC Criteria

December 8, 2019

First Posted (ACTUAL)

December 11, 2019

Study Record Updates

Last Update Posted (ACTUAL)

December 13, 2019

Last Update Submitted That Met QC Criteria

December 10, 2019

Last Verified

December 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Illness Myopathy

Subscribe